Alerus Financial’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-10,305
Closed -$1.96M 150
2018
Q3
$1.96M Sell
10,305
-15,665
-60% -$2.88M 0.27% 89
2018
Q2
$4.33M Sell
25,970
-4,297
-14% -$690K 0.61% 51
2018
Q1
$5.09M Buy
30,267
+18,794
+164% +$3.15M 0.73% 39
2017
Q4
$1.88M Sell
11,473
-7,536
-40% -$1.35M 0.27% 84
2017
Q3
$3.9M Buy
19,009
+921
+5% +$214K 0.57% 54
2017
Q2
$4.4M Buy
18,088
+198
+1% +$46.5K 0.65% 46
2017
Q1
$4.27M Sell
17,890
-1,986
-10% -$462K 0.66% 46
2016
Q4
$4.17M Sell
19,876
-1,526
-7% -$316K 0.67% 47
2016
Q3
$4.93M Buy
21,402
+4,628
+28% +$1.13M 0.8% 37
2016
Q2
$3.88M Buy
+16,774
New +$3.87M 0.65% 50

Other funds holding AGN

Alerus Financial's AGN Position: Q4 2018 in Review

Alerus Financial sold out of Allergan plc (AGN) in Q4 2018, closing a stake of 10,305 shares — an estimated $1.96M sold.

Alerus Financial first reported a position in AGN in Q2 2016 and held it in 10 quarters. The position peaked at $5.09M in Q1 2018. 1,007 funds tracked by Wall St. Rank hold AGN as of Q4 2018.

  • Alerus Financial reported no remaining Allergan plc position as of Q4 2018 after selling out during the quarter.
  • Alerus Financial sold 10,305 Allergan plc shares in Q4 2018, an estimated $1.96M.
  • Alerus Financial first reported a position in Allergan plc in Q2 2016 and held it in 10 quarters.
  • Alerus Financial's Allergan plc position peaked at $5.09M in Q1 2018.
  • 1,007 funds tracked by Wall St. Rank held Allergan plc as of Q4 2018.

Based on Alerus Financial's 13F filing for Q4 2018, filed 4 Feb 2019.